CD4 and cancer: We found that stromal cells, such as cancer-associated fibroblasts (CAFs), most immune cells, such as CD8+ T cells, CD4+ T cells, and antigen-presenting cells, were significantly higher in the low-risk group than in the high-risk group (Figure 5F).